Teva Pharmaceuticals just needs two more states to achieve agreements or agree to engage in a settlement accord with the generics giant for its participation in the US opioid epidemic.
According to the attorney general, Oklahoma has reached settlement agreements worth more than $226 million with three large drugstore chains and one opioid manufacturer.
Two healthcare providers in Santa Barbara and San Luis Obispo counties, including Dignity Health, have agreed to pay $22.5 million in settlement arrangements to resolve charges that they violated federal and state law by submitting phoney invoices to Medicaid.
Local governments in Northwest Florida and Miami-Dade County have filed lawsuits against the multinational consulting company McKinsey & Company for prior work in assisting with the marketing of opioids.
Philips has completed safety studies on several of its equipment nearly two years after first publicly raising concerns about the possible disintegration of the polyester-based polyurethane foam included in many of its CPAP and BiPAP machines and other breathing devices.
In its opening brief to the 7th U.S. Circuit Court of Appeals, 3M claimed that the judge misunderstood precedent, ignored significant evidence, and adopted an unduly narrow construction of his inherent jurisdiction to block action against 3M.
Pharma firms engaged in the selling of the heartburn medication Zantac have won a critical fight in a lawsuit brought by individuals who say the medicine caused them to develop cancer.
A court sentenced a man to life in prison with no possibility of parole after he drove his SUV into a Christmas parade in suburban Milwaukee, killing six people and injuring many more. He and his family argued that mental illness pushed him to do it.
According to federal regulators, at least 260 deaths have been linked to recalled Philips CPAP sleep apnea machines, BiPAP machines, and mechanical ventilators, which were taken off the market last year amid concerns that toxic particles from the sound abatement foam could enter the airways and users' lungs.
The United States District Judge presiding over all federal hernia mesh lawsuits involving Bard products will meet with lawyers involved in the litigation next week as preparations for a third and fourth bellwether trial, which are expected to have a significant impact on ongoing settlement talks to resolve thousands of claims.